Numerai’s Orthofix Medical OFIX Stock Holding History

Numerai’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,990	Closed	-$226K	–	190
2022 Q4	$226K	Buy	+10,990	New	+$194K	0.15%	104

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Numerai's OFIX Position: Q1 2023 in Review

Numerai sold out of Orthofix Medical (OFIX) in Q1 2023, closing a stake of 10,990 shares — an estimated $226K sold.

Numerai first reported a position in OFIX in Q4 2022 and held it in 1 quarter. The position peaked at $226K in Q4 2022. 162 funds tracked by Wall St. Rank hold OFIX as of Q1 2023.

Numerai reported no remaining Orthofix Medical position as of Q1 2023 after selling out during the quarter.
Numerai sold 10,990 Orthofix Medical shares in Q1 2023, an estimated $226K.
Numerai first reported a position in Orthofix Medical in Q4 2022 and held it in 1 quarter.
Numerai's Orthofix Medical position peaked at $226K in Q4 2022.
162 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2023.

Based on Numerai's 13F filing for Q1 2023, filed 12 May 2023.